scispace - formally typeset
Search or ask a question

Showing papers by "Richard J. Colonno published in 1993"


Journal ArticleDOI
TL;DR: Protein sequencing revealed that cleavage occurs between the Ala and Ser residues at amino acids 610/611 and 247/248 of the HSV-1 protease, which are highly conserved in homologous proteases of other herpes viruses.

86 citations


Patent
14 Oct 1993
TL;DR: In this article, a synthetically derived 67-nucleotide RNA substrate, containing a 32 P! labeled cap-1 structure was used to analyze parameters of influenza virus endonuclease activity.
Abstract: Novel capped oligonucleotides useful in treatment of influenza infection. A synthetically derived 67-nucleotide RNA substrate, containing a 32 P! labeled cap-1 structure was used to analyze parameters of influenza virus endonuclease activity. This substrate was specifically cleaved by the influenza virus polymerase to yield a single capped 11-nucleotide fragment capable of directly priming transcription. An analysis of systematic truncations of this RNA substrate in cleavage, elongation, and binding reactions demonstrated that the minimum chain length required for cleavage was one nucleotide past the cleavage site. In contrast, the minimum chain length required for priming activity was found to be 9 nucleotides, while a chain length of at least 4 nucleotides was required for efficient binding. Based on these chain length requirements, the present inventors show that a pool of capped oligonucleotides--too short to prime transcription but long enough to bind with high affinity to the viral polymerase--are potent inhibitors of cap-dependent in vitro transcription.

15 citations


Journal ArticleDOI
TL;DR: TGG-II-23A represents a new structural entry into the TIBO/Nevirapine class of inhibitors of HIV-1 reverse transcriptase, and is a mixed non-competitive inhibitor that exhibits the same template:primer selectivity as other non-nucleoside inhibitors.

11 citations